Lyra Therapeutics Inc. logo

Lyra Therapeutics Inc. (LYRA)

Market Open
11 Aug, 14:37
OTC PINK OTC PINK
$
0. 25
-0.03
-10.7143%
$
709.95K Market Cap
- P/E Ratio
- Div Yield
109 Volume
-1.01 Eps
$ 0.28
Previous Close
Add Transaction
Day Range
0.25 0.25
Year Range
0 8.75
Want to track LYRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Lyra Therapeutics Inc. (LYRA) Statistics

Valuation metrics

Market Cap 709.95K
Enterprise value 15.08M
Trailing P/E (ttm) -0.02
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 1.78
Price/Book (mrq) -0.58
Enterprise Value/Revenue 37.88
Enterprise Value/EBITDA -0.54

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 974
Average volume (90 days) 7.97K

Price summary

52-Week low 0
52-Week high 8.75
Beta -
50-Day moving average 0.51
200-Day moving average 0.89

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 28 May 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -72.66%
Operating margin -77.94%

Operational effectiveness

Return on assets -0.8%
Return on equity 12.11%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.86
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.02
Total debt (mrq) -
Total Debt/Equity (mrq) -2.82
Current ratio (mrq) 1.71%
Book value per share (mrq) -0.69

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -